RenovaCare Awarded U.S. Patent For SkinGun™ Device To Spray Stem Cells On To Wounds

Dec 06, 2016, RCAR OTC Disclosure & News Service RenovaCare, Inc., (RCAR), developer of the patented CellMist™ and SkinGun™ technologies* for isolating and spraying a patient’s own stem cells onto burns and wounds for rapid self-healing, today announced that the company has bolstered its patent portfolio with the issuance of a United States patent for its novel SkinGun™ device. The United States Patent and Trademark Office has granted an additional 30-month extension for the patent, providing protection beyond the
http://bit.ly/2g6QxTD